|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 362.50 CHF | +0.97% |
|
-0.14% | +4.02% |
| 11-28 | Swiss Market Index Ends Week Flat; Dottikon Shares Surge | MT |
| 11-28 | Dottikon Shares Jump on Upbeat Fiscal 2026 Outlook Amid Higher First-half Profit, Sales | MT |
| Capitalization | 5.01B 6.24B 5.38B 4.66B 8.68B 566B 9.34B 57.63B 22.72B 270B 23.41B 22.93B 986B | P/E ratio 2024 |
40.8x | P/E ratio 2025 | 24.2x |
|---|---|---|---|---|---|
| Enterprise value | 5.01B 6.24B 5.38B 4.66B 8.68B 566B 9.34B 57.63B 22.72B 270B 23.41B 22.93B 986B | EV / Sales 2024 |
10,053,944x | EV / Sales 2025 | 6,642,045x |
| Free-Float |
27.86% | Yield 2024 * |
-
| Yield 2025 | - |
More valuation ratios
* Estimated data
More news
More press releases
More news
| 1 day | +0.97% | ||
| 1 week | -0.14% | ||
| Current month | +4.02% | ||
| 1 month | +9.35% | ||
| 3 months | +16.00% | ||
| 6 months | +13.28% | ||
| Current year | +4.02% |
| 1 week | 353 |  | 365.5 |
| 1 month | 329.5 | | 367 |
| Current year | 344.5 | | 367 |
| 1 year | 151 | | 367 |
| 3 years | 151 | | 367 |
| 5 years | 151 | | 370 |
| 10 years | 20.05 | | 370 |
| Manager | Title | Age | Since |
|---|---|---|---|
Markus Blocher
CEO | Chief Executive Officer | 55 | 31/12/2002 |
Marlene Born
DFI | Director of Finance/CFO | 51 | 31/12/2005 |
Karin Krause
HRO | Human Resources Officer | 58 | 31/12/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
Markus Blocher
CHM | Chairman | 55 | 31/12/2011 |
| Director/Board Member | 69 | 30/06/2011 | |
Urs Brändli
BRD | Director/Board Member | 66 | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.97% | -0.14% | +68.60% | +31.34% | 6.24B | |
| +0.53% | -2.37% | +43.09% | +194.99% | 930B | |
| -0.41% | +6.98% | +48.72% | +28.81% | 527B | |
| -0.31% | -2.60% | +24.94% | +43.67% | 379B | |
| +0.93% | +2.38% | +31.46% | +17.91% | 371B | |
| +0.19% | -1.15% | +28.47% | +21.37% | 292B | |
| +0.98% | +1.37% | +29.42% | +36.42% | 276B | |
| -1.93% | -1.54% | +11.14% | +0.04% | 270B | |
| +6.49% | +1.95% | -32.44% | -19.12% | 268B | |
| +0.12% | +1.32% | +21.43% | +24.97% | 178B | |
| Average | +0.76% | +0.62% | +27.48% | +38.04% | 349.72B | |
| Weighted average by Cap. | +0.59% | +0.50% | +29.12% | +67.33% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 333M 415M 358M 310M 577M 37.65B 621M 3.83B 1.51B 17.96B 1.56B 1.52B 65.57B | 393M 489M 422M 366M 681M 44.39B 732M 4.52B 1.78B 21.18B 1.83B 1.8B 77.32B |
| Net income | 80.63M 100M 86.61M 75.06M 140M 9.12B 150M 927M 366M 4.35B 377M 369M 15.88B | 106M 132M 113M 98.29M 183M 11.94B 197M 1.21B 479M 5.69B 493M 483M 20.79B |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
875
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/01/26 | 362.50 CHF | +0.97% | 2,925 |
| 15/01/26 | 359.00 CHF | -1.51% | 5,015 |
| 14/01/26 | 364.50 CHF | +2.68% | 3,415 |
| 13/01/26 | 355.00 CHF | -0.84% | 5,911 |
| 12/01/26 | 358.00 CHF | -1.38% | 3,664 |
Delayed Quote Swiss Exchange, January 16, 2026 at 04:31 pm
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
362.50CHF
Average target price
460.00CHF
Spread / Average Target
+26.90%
Annual profits - Rate of surprise
- Stock Market
- Equities
- DESN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition